Table 1. Measures of oculomotor control.
Placebo |
Caffeine |
Bupropion |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre exercise |
Post exercise |
Pre exercise |
Post exercise |
Pre exercise |
Post exercise |
|||||||
Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | |
Prosaccade | ||||||||||||
Peak velocity(° · s−1) | 468 | 47 | 433 | 88 | 454 | 44 | 485 | 50 | 458 | 37 | 455 | 62 |
Gap condition | 466 | 50 | 434 | 87 | 453 | 44 | 485 | 52 | 456 | 37 | 451 | 61 |
Overlap condition | 470 | 44 | 432 | 90 | 454 | 48 | 485 | 51 | 460 | 39 | 459 | 64 |
Latency(ms) | 167 | 18 | 174 | 26 | 166 | 17 | 171 | 16 | 167 | 18 | 170 | 26 |
Gap condition | 155 | 14 | 160 | 18 | 151 | 16 | 153 | 18 | 154 | 14 | 155 | 20 |
Overlap condition | 179 | 26 | 187 | 34 | 182 | 20 | 189 | 19 | 181 | 25 | 185 | 33 |
Amplitude(°) | 9 | 0.5 | 9 | 0.9 | 9 | 0.4 | 9 | 0.6 | 9 | 0.6 | 9 | 0.9 |
Gap condition | 9 | 0.6 | 9 | 0.5 | 9 | 0.6 | 9 | 0.7 | 9 | 0.6 | 9 | 0.9 |
Overlap condition | 9 | 0.4 | 9 | 1.5 | 9 | 0.4 | 9 | 0.6 | 9 | 0.7 | 9 | 0.9 |
Task performance(%correct) | 97 | 4 | 96 | 2 | 96 | 5 | 97 | 5 | 98 | 3 | 95 | 5 |
Gap condition | 95 | 6 | 96 | 4 | 92 | 9 | 95 | 8 | 95 | 5 | 92 | 8 |
Overlap condition | 99 | 3 | 100 | 1 | 99 | 1 | 99 | 2 | 100 | 1 | 98 | 3 |
Antisaccade | ||||||||||||
Peak velocity(° · s−1) | 444 | 62 | 413 | 63 | 441 | 73 | 462 | 82 | 432 | 40 | 413 | 62 |
Gap condition | 457 | 61 | 411 | 70 | 443 | 76 | 465 | 84 | 433 | 41 | 421 | 66 |
Overlap condition | 432 | 66 | 416 | 58 | 439 | 70 | 458 | 81 | 431 | 43 | 404 | 61 |
Latency(ms) | 231 | 61 | 247 | 43 | 238 | 38 | 233 | 37 | 242 | 45 | 242 | 52 |
Gap condition | 228 | 63 | 239 | 47 | 232 | 41 | 225 | 43 | 240 | 49 | 236 | 56 |
Overlap condition | 233 | 60 | 254 | 40 | 243 | 35 | 241 | 32 | 244 | 42 | 248 | 50 |
Amplitude(°) | 9 | 2.1 | 9 | 1 | 9 | 1.8 | 9 | 1.6 | 9 | 1.8 | 9 | 1.5 |
Gap condition | 9 | 2.1 | 9 | 1 | 9 | 1.8 | 9 | 1.6 | 9 | 1.7 | 9 | 1.4 |
Overlap condition | 9 | 2.1 | 9 | 1 | 9 | 1.9 | 9 | 1.6 | 9 | 2 | 9 | 1.7 |
Task performance(% correct) | 82 | 17 | 87 | 8 | 87 | 7 | 87 | 8 | 88 | 10 | 85 | 11 |
Gap condition | 76 | 18 | 82 | 12 | 83 | 11 | 80 | 13 | 82 | 15 | 78 | 14 |
Overlap condition | 87 | 18 | 91 | 5 | 92 | 4 | 94 | 4 | 93 | 7 | 92 | 8 |
Smooth pursuit | ||||||||||||
Gain | 0.91 | 0.26 | 0.87 | 0.29 | 0.89 | 0.26 | 0.87 | 0.3 | 0.87 | 0.23 | 0.9 | 0.31 |
5° · s−1 stimulus | 0.97 | 0.27 | 0.96 | 0.26 | 0.96 | 0.25 | 0.94 | 0.33 | 0.93 | 0.23 | 0.96 | 0.29 |
10° · s−1 stimulus | 0.91 | 0.23 | 0.91 | 0.27 | 0.9 | 0.25 | 0.86 | 0.26 | 0.89 | 0.23 | 0.94 | 0.32 |
30° · s−1 stimulus | 0.75 | 0.19 | 0.66 | 0.25 | 0.73 | 0.22 | 0.7 | 0.22 | 0.74 | 0.17 | 0.67 | 0.23 |
Optokinetic Nystagmus | ||||||||||||
Slow phase gain | 0.67 | 0.11 | 0.64 | 0.11 | 0.74 | 0.08 | 0.72 | 0.07 | 0.7 | 0.1 | 0.73 | 0.1 |
5° · s−1 stimulus | 0.72 | 0.1 | 0.65 | 0.06 | 0.71 | 0.06 | 0.7 | 0.07 | 0.67 | 0.07 | 0.7 | 0.09 |
10° · s−1 stimulus | 0.64 | 0.21 | 0.65 | 0.16 | 0.76 | 0.14 | 0.74 | 0.1 | 0.72 | 0.16 | 0.75 | 0.14 |
Quick phase amplitude(°) | 5 | 1.4 | 4 | 1.5 | 5 | 1.2 | 5 | 1.9 | 5 | 1.5 | 5 | 1.8 |
5° · s−1 stimulus | 4 | 1.7 | 4 | 1.2 | 4 | 1.3 | 5 | 2.2 | 4 | 1.8 | 4 | 1.6 |
10° · s−1 stimulus | 5 | 1.4 | 5 | 1.8 | 5 | 1.3 | 6 | 1.9 | 6 | 1.4 | 6 | 2 |
Quick phase peak velocity(° · s−1) | 245 | 54 | 203 | 54 | 235 | 52 | 245 | 58 | 250 | 47 | 237 | 62 |
5° · s−1 stimulus | 223 | 59 | 182 | 51 | 213 | 52 | 232 | 71 | 218 | 23 | 208 | 57 |
10° · s−1 stimulus | 258 | 59 | 216 | 63 | 248 | 53 | 254 | 54 | 266 | 44 | 254 | 66 |
Kinematic and task performance measures derived from prosaccade, antisaccade, smooth pursuit and OKN visual tasks, pre and post exercise for placebo, caffeine and NDRI treatments.